SUNRISE TECHNOLOGIES INTERNATIONAL INC
8-K, 1997-03-27
DENTAL EQUIPMENT & SUPPLIES
Previous: IROQUOIS BANCORP INC, 10-K, 1997-03-27
Next: PEOPLES SAVINGS FINANCIAL CORP /CT/, 10-K, 1997-03-27



               SECURITIES AND EXCHANGE COMMISSION
                     WASHINGTON, D.C.  20549
                                
                                
                                
                            FORM 8-K
                                
                         CURRENT REPORT
             PURSUANT TO SECTION 13 OR 15(D) OF THE
                 SECURITIES EXCHANGE ACT OF 1934
                                
                                

Date of Report (Date of earliest event reported): March 12, 1997
                                
            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
       (Exact Name of Registrant as Specified in Charter)
                                
                                
      Delaware               0-17816              77-0148208
  (State or other       (Commission File        (IRS Employer
  jurisdiction of            Number)         Identification No.)
   incorporation)
          




           47257 Fremont Boulevard, Fremont, California     94538
           (Address of Principal Executive Offices)    (Zip Code)



Registrant's telephone number, including area code   510-623-9001

                                
                                
                               N/A
  (Former Name or Former Address, if Changed Since Last Report)

<PAGE>

                                
ITEM 7.        FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS.

 EXHIBIT   DESCRIPTION

    4      INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS

   4.1       Form of 5% Convertible Notes due 1999

   4.2       Form of Security Agreement relating to 5%
Convertible Notes due 1999

   4.3       Form of Registration Rights Agreement

ITEM 9.        SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S

     On March 12, 1997, Sunrise Technologies International, Inc.
(the "Registrant") issued and sold, without registration under
the Securities Act of 1933, as amended (the "Securities Act"), in
reliance on Regulation S thereunder, an aggregate principal
amount of $500,000 5% convertible notes due 1999 ("Regulation S
Notes") and warrants to purchase common stock of the Registrant
("Regulation S Warrants").  The Regulation S Notes are
convertible into common stock of the Registrant ("Common Stock")
at a conversion price of $1.00 of Regulation S Notes for each
share of Common Stock.  A Regulation S Warrant to purchase one
share of Common Stock, at an exercise price of $1.25, was issued
without additional consideration for each $2.00 of Regulation S
Notes purchased.

     The Regulation S Notes and Regulation S Warrants were issued
as part of a private placement (the "Private Placement") of an
aggregate principal amount of $4,100,750 5% convertible notes due
1999, which include the Regulation S Notes (collectively,
"Notes"), and accompanying warrants to purchase Common Stock
(collectively with the Regulation S Warrants, "Warrants").
Closings of tranches of the Private Placement were held on
February 12, 1997, February 26, 1997, March 7, 1997 and March 12,
1997 (each, a "Closing").  The Notes and Warrants other than the
Regulation S Notes and Regulation S Warrants were offered and
sold by the Registrant in reliance on Regulation D under the
Securities Act to "accredited investors" within the meaning of
Rule 501 under the Securities Act.  Notes issued in reliance on
Regulation D under the Securities Act are convertible into Common
Stock at a conversion price of $0.875 of Notes for each share of
Common Stock, and a Warrant to purchase one share of Common
Stock, at an exercise price of $1.00, was issued without
additional consideration for each $1.75 of Notes, other than
Regulation S Notes, purchased.

     The Notes are convertible at any time prior to maturity, at
the option of the holders thereof, at the respective conversion
price set forth above, subject to adjustment for any stock
dividends, certain distributions, stock splits or combinations or
reclassifications of Common Stock.  The Warrants are exercisable
at any time for five years from the date of issuance, by
presentation and surrender thereof to the Registrant, together
with a duly executed Purchase Form and full and proper payment of
the exercise price.  An aggregate of 4,686,572 shares of Common
Stock have been reserved for issuance upon conversion of the
Notes, and an aggregate 

<NOTE>


of 2,343,286 shares of Common Stock have
been reserved for issuance upon exercise of the Warrants.  The
Registrant has agreed to register under the Securities Act the
shares of Common Stock issuable upon conversion of the Notes and
the shares of Common Stock issuable upon exercise of the
Warrants.

     As security for the payment of the Notes, the Registrant
granted to Pennsylvania Merchant Group Ltd ("PMG"), the duly
appointed agent for the purchasers of the Notes, a security
interest in the Registrant's ophthalmic patents and applications
for patents and related assets, as more particularly described in
the Security Agreement dated as of February 12, 1997, as amended.

     For its services as placement agent for the Private
Placement, PMG received a fee of 7 1/2% of the gross proceeds of the
Private Placement and the right to purchase, for a nominal
purchase price, warrants to purchase an aggregate of 234,329
shares of common stock of the Registrant ("PMG Warrants"), an
amount equal to 5% of the shares of common stock into which the
Notes are convertible.  The PMG Warrants, when issued, will be
exercisable, at an exercise price of $0.875 per share, at any
time from their date of issue until the fifth anniversary of the
respective Closing.

<PAGE>

                          
                            SIGNATURE
                                
     Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.

                         SUNRISE TECHNOLOGIES INTERNATIONAL, INC.



Dated:  March 25, 1997   By:    /s/ David W. Light
                              David W. Light
                              Chief Executive Officer and Chairman
                                 of the Board



                              NOTE

ALL  CAPITALIZED  TERMS SHALL BE DEEMED TO HAVE  THE  DEFINITIONS
ASCRIBED  TO  THEM  IN  THE PURCHASE AGREEMENTS,  AS  DEFINED  IN
SECTION 1 OF THIS DOCUMENT.

                                          _________________, 1997


          FOR VALUE RECEIVED, SUNRISE TECHNOLOGIES INTERNATIONAL,
INC., a Delaware corporation ("Maker"), hereby promises to pay to
the                           order                            of
_________________________________________________________ or  its
registered  assigns ("Payee"), in legal and lawful money  of  the
United    States    of    America,   the   aggregate    sum    of
_________________________________________________________
($__________________)  with interest  thereon  according  to  the
terms  hereof.  The principal amount hereof, and all accrued  and
unpaid  interest  hereon,  shall be paid  in  full  to  Payee  on
_____________  (the  date two years from  the  Closing  Date,  as
defined in the Purchase Agreement).

          Section 1.  Purchase Agreements.  This Note and certain
other  similar notes aggregating $[     ] principal  amount  have
been  issued  pursuant  to  a  U.S.  Note  and  Warrant  Purchase
Agreement  dated  of  even  date  herewith  among  Maker,  Payee,
Pennsylvania  Merchant  Group  Ltd.  ("PMG")  and  certain  other
investors  (the "U.S. Purchase Agreement") and an  Offshore  Note
and  Warrant Purchase Agreement dated of even date herewith among
Maker,  Payee,  PMG  and certain other investors  (the  "Offshore
Purchase  Agreement").  Pursuant to the U.S.  Purchase  Agreement
and  the Offshore Purchase Agreement (collectively, the "Purchase
Agreements") warrants (the "Warrants") to purchase Maker's Common
Stock have also been issued to Payee.

          Section  2.   Interest.  Interest shall accrue  on  the
outstanding principal hereof at an annual rate of 5.0%.   Accrued
interest  shall  be payable at maturity or conversion.   Interest
shall  be  payable in cash or, at the option of Maker, shares  of
Maker's Common Stock, calculated based on the average of the last
reported sale prices for the last five days prior to the  payment
date.

          Section  3.   Conversion.  Subject  to  the  conditions
herein contained, this Note shall be convertible at any time  and
from  time to time, at the option of Payee, into fully  paid  and
nonassessable  shares of Maker's Common Stock upon  surrender  to
Maker of this Note; and upon receipt by Maker of such surrendered
Note  with any appropriate endorsement thereon, and upon  written
notice to Maker by Payee of Payee's election to convert the  same
and  setting forth the name or names in which shares  of  Maker's
Common Stock are to be issued, Payee shall be entitled to receive
a  certificate or certificates representing the shares of Maker's
Common   Stock  into  which  this  Note  is  convertible.    Such
conversion shall be deemed to have been made immediately prior to
the close of business on the date of such surrender of this Note,
and  the  person  or persons entitled to receive  the  shares  of
Maker's  Common  Stock  issuable upon such  conversion  shall  be
treated for all purposes as the record holder or holders of  such
shares  of Common Stock as of such date; provided, however,  that
any  such surrender on any date when the stock transfer books  of
Maker  shall  be  closed shall constitute the person  or  persons
entitled  to receive the shares of 

                                  1
<PAGE>


Maker's Common Stock  issuable
upon  such  conversion as the record holder or  holders  of  such
shares  of Maker's Common Stock for all purposes at the close  of
business on the next succeeding day on which such transfer  books
are  open.  Maker's Board of Directors shall at all times reserve
a  sufficient number of authorized but unissued shares of Maker's
Common Stock to cover the conversion of any outstanding Notes.

          (a)  Conversion Price.  The basis for the conversion of
this note shall be the Conversion Price in effect at the time  of
conversion.  Initially, the Conversion Price shall be  $[      ].
In   connection  with  effecting  any  transfer  to   Maker   for
cancellation  of  this  Note upon conversion  of  the  same  into
Maker's  Common  Stock, Maker may, but shall not be  obliged  to,
issue  a certificate or certificates for fractions of a share  of
Maker's Common Stock.  If Maker elects not to issue a certificate
or certificates for fractions of a share of Maker's Common Stock,
Maker shall pay in lieu thereof an amount equal to the Conversion
Price of such fractional share (computed to the nearest hundredth
of  a  share) in effect at the close of business on the  date  of
conversion.

          (b)   Adjustment  of  Conversion Price  and  Number  of
Shares.   The  number of shares of Maker's Common Stock  issuable
upon  the  exercise or exchange of this Note and  the  Conversion
Price  shall be subject to adjustment from time to time upon  the
occurrence of certain events, as follows:

               (i)   Adjustment for Change in Capital Stock.   If
at any time after the Closing Date, Maker:

                    (1)       pays   a   dividend  or   makes   a
                              distribution on its Common Stock in
                              shares of its Common Stock;
                              
                    (2)       subdivides  its outstanding  shares
                              of  Common  Stock  into  a  greater
                              number of shares;
                              
                    (3)       combines its outstanding shares  of
                              Common  Stock into a smaller number
                              of shares;
                              
                    (4)       makes  a distribution on its Common
                              Stock  in  shares  of  its  capital
                              stock other than Common Stock; or
                              
                    (5)       issues  by reclassification of  its
                              Common  Stock  any  shares  of  its
                              capital stock;
                              
then  the  Conversion Price in effect immediately prior  to  such
action shall be adjusted so that Payee may receive, upon exchange
of this Note, the number of shares of Common Stock of Maker which
Payee would have owned immediately following such action if Payee
had exchanged this Note immediately prior to such action.

          Any  adjustment  of the Conversion Price  shall  become
effective  immediately after the record date in  the  case  of  a
dividend  or  distribution, and immediately after  the  effective
date   in   the   case   of   a   subdivision,   combination   or
reclassification.

                                  2
<PAGE>


          (ii)  Adjustment for Other Distributions.   If  at  any
time after the Closing Date, the Maker distributes to all holders
of  its  Common  Stock any of its assets or debt securities,  the
Conversion  Price following the record date shall be adjusted  in
accordance with the following formula:

                          C' = C x  M-F
                                     M
          
          
where:   C'     =     the adjusted Conversion Price.
                      
         C      =     the  Conversion Price immediately prior  to
                      the adjustment.
                      
         M      =     the   current  market  price  (as   defined
                      below)  per  share of Maker's Common  Stock
                      on the record date of the distribution.
                      
         F      =     the   aggregate  fair  market   value   (as
                      conclusively  determined by  Maker's  Board
                      of  Directors) on the record  date  of  the
                      assets   or   debt   securities    to    be
                      distributed  divided  by  the   number   of
                      outstanding   shares  of   Maker's   Common
                      Stock.
                      
          The  adjustment shall be made successively whenever any
such  distribution is made and shall become effective immediately
after  the  record  date  for the determination  of  stockholders
entitled  to  receive the distribution.  In the event  that  such
distribution  is  not actually made, the Conversion  Price  shall
again  be adjusted to the Conversion Price as determined  without
giving  effect to the calculation provided hereby.  In  no  event
shall  the  Conversion Price be adjusted to an amount  less  than
zero.

          This  Section 3(b)(ii) does not apply to cash dividends
or  cash  distributions  paid  out  of  consolidated  current  or
retained earnings as shown on the books of Maker and paid in  the
ordinary course of business.

          (iii)      Current  Market Price.  The  current  market
price  per  share  of Maker's Common Stock on  any  date  is  the
average  of  the  Quoted  Prices of  the  Common  Stock  for  the
30 consecutive trading days commencing 45 trading days before the
date in question.  The "Quoted Price" of Maker's Common Stock  is
the last reported sales price of Maker's Common Stock as reported
by  Nasdaq, or the primary national securities exchange on  which
Maker's  Common Stock is then quoted; provided, however, that  if
quotes  for the Common Stock are not reported by Nasdaq  and  the
Maker's  Common  Stock is neither traded on the  Nasdaq  National
Market,  on  a national securities exchange, on the Nasdaq  Small
Cap  Market nor on the OTC Electronic Bulletin Board,  the  price
referred  to above shall be the price reflected in the  over-the-
counter market as reported by the National Quotation Bureau, Inc.
or  any organization performing a similar function, and provided,
further,  that  if  Maker's Common Stock  is  not  then  publicly
traded, the market price shall equal the Conversion Price.

          Section  4.   Optional Redemption by the Company.   The
Notes are subject to redemption, at the option of the Company, in
whole  but  not in part, at any time on or after 

                                  3
<PAGE>


March 31,  1997,
upon not more than 60 nor fewer than 30 days' notice prior to the
date  fixed  by  the board of directors of the Company  for  such
redemption  (the  "Redemption Date"), which  notice  ("Redemption
Notice") shall be irrevocable.  Any such redemption shall be at a
price  equal to the principal of the Notes then outstanding  plus
accrued and unpaid interest to the Redemption Date.  Upon issuing
a  Redemption Notice, the Company shall establish an account with
a  federally  insured bank (the "Redemption Account")  and  shall
deposit  into  the  Redemption Account an  amount  equal  to  the
Redemption Price.  At any time prior to the Redemption Date,  any
holder  of  Notes  may convert such Notes into  Common  Stock  in
accordance  with  Section  3 of the Notes,  in  which  case,  the
Company may withdraw from the Redemption Account the amount  that
otherwise would have been payable to such Noteholder.

          Section  5.   Place of Payment.  All  payments  due  to
Payee  hereunder shall be paid to Payee at the following  address
on or before the due date of such payment as provided herein: c/o
Pennsylvania  Merchant Group Ltd., Four Falls  Corporate  Center,
West  Conshohocken, Pennsylvania 19428-2961,  or  to  such  other
address of which Payee shall give written notice to Maker.

          Section 6.  Events of Default and Remedies.  If any  of
the  following  events  of default (individually,  an  "Event  of
Default")  shall occur for any reason whatsoever (and whether  it
shall  be  voluntary or involuntary or occur or  be  affected  by
operation of law or otherwise):

               A.    Maker fails to make payment when due of  any
principal  or interest payable under this Note, and such  failure
continues  for a period of 5 days after written notice that  such
payment is due and unpaid;

               B.     Maker   defaults  in  the   observance   or
performance  of  any material agreement or condition  under  this
Note or the Warrants, and such default continues for a period  of
30 days after written notice of such default is given to Maker by
Payee;

               C.    Any representation or warranty made by Maker
in  the Purchase Agreements shall prove to have been false in any
material respect on the date when made;

               D.     Maker  shall  default  under  any  material
agreement for borrowed money which causes the other party thereto
to accelerate such obligation;

               E.   Maker shall (i) file, or consent by answer or
otherwise  to the filing against it of a petition for  relief  or
reorganization or arrangement or any other petition in bankruptcy
or  insolvency  law of any jurisdiction, (ii) make an  assignment
for   the  benefit  of  its  creditors,  (iii)  consent  to   the
appointment  of a custodian, receiver, trustee, or other  officer
with  similar powers of itself or of any substantial part of  its
property,  (iv)  be  adjudicated insolvent or  be  liquidated  or
(v)  take  appropriate  action for the  purpose  of  any  of  the
foregoing;

               F.     A   court  or  governmental  authority   of
competent   jurisdiction  shall  enter  an  order  appointing   a
custodian, receiver, trustee or other officer with similar powers
with   respect  to  Maker  or  any  substantial  amount  of   its
properties, or if an order for relief with respect to Maker shall
be   entered  in  any  case  or  proceeding  for  liquidation  or
reorganization  or otherwise 

                                 4
<PAGE>


to take advantage of any  bankruptcy
or   insolvency  law  of  any  jurisdiction,  or   ordering   the
dissolution,  winding  up or liquidation  of  Maker,  or  if  any
petition  for any such relief shall be filed against  Maker,  and
such  order  or petition shall not be dismissed or stayed  within
60  days  after the date of such filing, then automatically  upon
the  occurrence  of  such  Event of  Default  the  entire  unpaid
principal  amount  of, and the unpaid accrued interest  on,  this
Note shall become immediately due and payable.

          Section  7.   Security.  To secure Maker's  obligations
under the Notes, Maker has designated Pennsylvania Merchant Group
Ltd.,  as  agent  for  the  Payees, and has  granted  a  security
interest  in  all  of its pending and issued ophthalmic  patents,
pursuant to a pledge agreement dated _____________, 1997.

          Section  8.   Additional Remedies.   If  any  Event  of
Default  hereunder  shall have occurred,  Payee  may  proceed  to
protect and enforce its rights under this Note by exercising such
remedies  as  are  available to it in respect thereof  under  the
terms of this Note or applicable law, either by suit in equity or
by  action  at law, or both, whether for specific performance  of
any agreement contained in this Note or in aid of the exercise of
any  power  granted  in this Note. No remedy is  intended  to  be
exclusive and each such remedy shall be cumulative.

          Section  9.   Amendments  and  Waivers.   PMG  and  the
holders  of at least 80% of the outstanding principal balance  of
all  Notes  issued  pursuant to the Purchase Agreements  may,  by
written  instrument: (a) extend the time for the  performance  of
any  of the obligations or other acts of Maker, including without
limitation, payment obligations; (b) waive compliance with any of
the  covenants  of Maker contained herein and (c)  waive  Maker's
performance  of  any  of its obligations hereunder.  Neither  the
failure  of Payee nor any delay on the part of Payee to  exercise
any right, power or privilege under this Note shall operate as  a
waiver thereof, nor shall any single or partial exercise by Payee
of  any  right, power or privilege preclude any other or  further
exercise of that or any other right, power or privilege.

          Section 10.  Expenses.  Upon the occurrence of an Event
of  Default  hereunder, Maker shall reimburse Payee promptly  for
all reasonable counsel fees, costs and other expenses incurred by
Payee  in  connection with the collection and/or  enforcement  of
this Note.

          Section 11.  Payment Due on Holidays.  If the principal
of  or  interest on this Note falls due on a Saturday, Sunday  or
legal holiday at the place of payment, such payment shall be made
on  the next succeeding business day and such extended time shall
be included in computing interest.

          Section   12.    Applicable  Law.   The   construction,
interpretation and enforcement of this Note shall be governed  by
the laws of the Commonwealth of Pennsylvania.

          Section  13.  Severability.  If any provision  of  this
Note  shall  be  held  invalid under any  applicable  laws,  such
invalidity shall not affect any other provision of this Note that
can  be  given effect without the invalid provision and, to  this
end, the provisions hereof are severable.

                                 5
<PAGE>


          IN  WITNESS WHEREOF, and intending to be legally  bound
hereby,  Maker has caused this Note to be executed and  delivered
by  its proper and duly authorized officers as of the date  first
above written.

          
          
SUNRISE TECHNOLOGIES INTERNATIONAL, INC.



By:_____________________________________________
     David Light
     Chairman of the Board and Chief Executive Officer




Attest:__________________________________________
     Secretary

                                 6


                       SECURITY AGREEMENT


          THIS SECURITY AGREEMENT (this "Security Agreement") is
made this ___ day of ___________, 1997 by SUNRISE TECHNOLOGIES
INTERNATIONAL, INC., a Delaware corporation ("Company"), in favor
of PENNSYLVANIA MERCHANT GROUP LTD as agent (the "Agent") for the
investors (as defined below).


                      W I T N E S S E T H:
                                
          WHEREAS, pursuant to a U.S. Note and Warrant Purchase
Agreement dated of even date herewith (as amended from time to
time, the "U.S. Agreement") by and among Company and each of the
persons and entities listed on the Schedule of Investors attached
hereto as Exhibit A (each such person of entity is referred to
herein as a "U.S. Investor" and collectively, the "U.S.
Investors"), and an Offshore Note and Warrant Purchase Agreement
dated of even date herewith (as amended from time to time, the
"Offshore Agreement") by and among Company and each of the
persons and entities listed on the Schedule of Investors attached
thereto as Exhibit A (each such person or entity is referred to
herein as an "Offshore Investor" and collectively the "Offshore
Investors"), Company has authorized the issue and sale of up to
$[     ] face amount of its Convertible Notes (the "Notes") and
Warrants to purchase up to [     ] of its Common Shares, $0.001
par value (the "Warrants"); and

          WHEREAS, subject to the terms and conditions of the
U.S. Agreement and the Offshore Agreement (collectively, the
"Agreements"), Company has agreed to sell to the U.S. Investors
and the Offshore Investors (collectively, the "Investors") and
each of the Investors, severally and not jointly, has agreed to
purchase from Company the number of Notes and Warrants
(collectively, the "Securities") set forth opposite each
Investor's name on Exhibit A to the Agreements at the price set
forth on such Exhibit A; and

          WHEREAS, it is a condition to the Investors'
obligations to purchase the Securities pursuant to the Agreements
that Company shall have executed and delivered this Security
Agreement in favor of the Agent on behalf of the Investors.

          NOW, THEREFORE, in consideration of the foregoing
premises and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, and intending
to be legally bound, Company hereby agrees that the Agent, on
behalf of the Investors, shall have the rights, remedies and
benefits hereinafter set forth.

          1.   As security for the payment of the Notes, Company
hereby grants to the Agent, on behalf of the Investors, a
security interest in the ophthalmic patents or applications for
patents owned by Company or in which Company has an interest
listed on Schedule A attached hereto, or any related books or
records, accessions or substitutions thereof or thereto, and any
part thereof (collectively, the "Collateral").

                                 1
<PAGE>


          2.   Anything herein to the contrary notwithstanding,
(a) Company shall remain liable under any contracts and
agreements related to or included in the Collateral to perform
all of its duties and obligations thereunder to the same extent
as if this Security Agreement had not been executed, (b) the
exercise by the Agent of any of the Agent's rights hereunder
shall not release Company from any of its duties or obligations
under any contracts and agreements related to or included in the
Collateral, and (c) neither the Agent nor any Investors shall
have any obligation or liability under any contracts and
agreements related to or included in the Collateral by reason of
this Security Agreement, nor shall the Agent or any Investors be
obligated to perform any of the obligations or duties of Company
thereunder or to take any action to collect or enforce any claim
for payment assigned hereunder.

          3.   Company represents and covenants that:

               a.   Its chief executive office and the office
where its records are kept concerning the Collateral is located
at 47257 Fremont Boulevard, Fremont, California 94538.

               b.   It will promptly notify and provide the agent
with a complete description of the opening of any new places of
business, the closing of any existing places of business, the
conduct of business under any names or through any entities other
than those set forth above and the relocation of any of the
records concerning the Collateral.  Company will furnish to the
Agent from time to time statements and schedules further
identifying and describing the Collateral and such other reports
in connection with the Collateral as the Agent may reasonably
request, all in reasonable detail.

               c.   It has good title to the Collateral, free and
clear of any liens and encumbrances, excepting the security
interest granted hereby.

               d.   This Security Agreement creates a valid and
enforceable security interest in the Collateral securing the
payment of the Notes, and upon the filing of the necessary
financing statements, such security interest will be a perfected
security interest.

               e.   Except for any filings required with the
United States Patent and Trademark Office, no authorization,
approval or other action by, and no notice to or filing with, any
governmental authority or regulatory body is required either (i)
for the grant by Company of the security interest granted hereby
or for the execution, delivery or performance of this Security
Agreement by Company, or (ii) except the filing of financing
statements, for the perfection of or the exercise by the Agent,
on behalf of the Investors, of rights and remedies hereunder.

          4.   At any time and from time to time, upon the
reasonable request of the Agent, Company shall, at its own
expense:

               a.   Defend the Collateral against the claims and
demand of all persons and entities.

                                 2
<PAGE>


               b.   Give, execute, deliver and filing in the
proper governmental offices, any instrument, paper or document,
including but not limited to one or more financing statements
under the Uniform Commercial Code, satisfactory to the Agent, or
take any action, which the Agent may deem necessary or desirable,
in order to create, preserve, perfect, extend, modify, terminate
or otherwise affect the security interest granted pursuant
hereto, or to enable the Agent to exercise or enforce any of the
Agent's rights hereunder.

               c.   Pay, or reimburse the Agent and the Investors
in the amount of, all expenses (including reasonable fee and
expenses of attorneys, experts and agents) reasonably incurred by
such persons in connection with the exercise, defense or
assertion of any rights or interests of the Agent and the
Investors hereunder, or the enforcement of any provisions hereof.

          5.   Company shall not, without the prior written
consent of the Investors, (i) transfer, sell or assign any of the
Collateral except on customary terms in the ordinary course of
business; (ii) allow or permit any other security interest or
lien to attach thereto, other than any other security interests
or liens permitted under the Agreements; (iii) file, or authorize
or permit to be filed, in any jurisdiction any financing
statement relating to any of the Collateral unless the Agent, on
behalf of the Investors, is named as sole secured party; (iv)
permit any of the Collateral to be levied upon under any legal
process; or (v) permit anything to be done that may materially
impair the value of any of the Collateral or the security
intended to be afforded hereby.

          6.   Company hereby authorizes the Agent to file one or
more financing or continuation statements, and amendments
thereto, relative to all or any part of the Collateral without
the signature of Company where permitted by law.  A carbon,
photographic, or other reproduction of this Security Agreement or
any part thereof shall be sufficient as a financing statement
where permitted by law.  Company shall furnish to the Agent from
time to time statements and schedules further identifying and
describing the Collateral and such other reports in connection
with the Collateral as the Agent may request, all in reasonable
detail.

          7.   Upon default by Company in the performance of any
covenant or agreement herein or in the Agreement or any other
agreement or document covering the Notes, or in the discharge,
payment or performance of the Notes, or if any representation or
warranty herein should prove untrue in any material respect, the
Agent, on behalf of the Investors, shall have with respect to the
Collateral all of the rights and remedies of a secured party
under the Uniform Commercial Code or any other applicable law and
all rights provided herein or in any other applicable security,
loan or other agreement, all of which rights and remedies shall,
to the full extent permitted by law, be cumulative.  The Agent
may require Company at its expense to assemble the Collateral or
any part thereof and make it available to the Agent, on behalf of
the Investors, at a place to be designated by the Agent, which is
reasonably convenient to the Agent and Company.  The Agent, on
behalf of the Investors, may sell the Collateral or any part
thereof in one or more parcels at public or private sale, at any
of the Agent's offices or elsewhere, for cash, on credit or for
future delivery, and at such price or prices and upon such other
terms as the Agent may deem commercially reasonable.  Any notice
of sale, disposition or other intended action by the Agent, sent
to Company at the address specified above, or such other address of 

                                 3
<PAGE>


Company as may from time to time be shown on the Agent's
records, at least thirty (30) days prior to such action, shall
constitute reasonable notice to Company.

          8.   The powers conferred on the Agent hereunder are
solely to protect the Agent's interest in the Collateral and
shall not impose any duty upon the Agent to exercise any such
powers.  Except for the safe custody of any Collateral in the
Agent's possession and the accounting for monies actually
received by the Agent hereunder, the Agent shall have no duty as
to any Collateral or as to the taking of any necessary steps to
preserve any right of or against other parties pertaining to any
Collateral.  Company shall indemnify the Agent and each Investor
from and against any and all claims, losses and liabilities
growing out of or resulting from this Security Agreement
(including, without limitation, enforcement of this Security
Agreement) or the Agent's or any Investor's interest in the
Collateral, except claims, losses or liabilities resulting from
the Agent's or such Investor's respective gross negligence of
wilful misconduct.

          9.   No provisions hereof shall be modified except by a
writing signed by the Agent and Company expressly referring to
the provision hereof so modified.

          10.  This Security Agreement shall be binding upon and
shall inure to the benefit of the assigns or successors of
Company and the Agent.

          11.  No delay, failure to enforce, or single or partial
exercise on the part of the Agent in connection with any of the
Agent's rights hereunder shall constitute an estoppel or waiver
thereof, or preclude other or further exercise or enforcement
thereof and no waiver of any default hereunder shall be a waiver
of any subsequent default.

          12.  This Security Agreement shall be governed as to
its validity, interpretation and effect in accordance with the
laws of the Commonwealth of Pennsylvania, except as required by
mandatory provisions of law and except if the validity or
perfection of the security interest hereunder, or remedies
hereunder, in respect of any particular Collateral are governed
by the laws of a jurisdiction other than Pennsylvania.  Unless
the context otherwise requires, all terms used herein which are
defined in the Uniform Commercial Code as enacted in Pennsylvania
shall have the meanings therein stated.

          IN WITNESS WHEREOF, this Security Agreement has been
executed in Fremont, California on the day and year first above
written.


                                   SUNRISE TECHNOLOGIES
                                   INTERNATIONAL, INC.



                                   By:  _________________________
                                        Name:     David W. Light
                                        Title:    Chief Executive
                                                  Officer

                                 4


                  REGISTRATION RIGHTS AGREEMENT



          This  Registration Rights Agreement (this  "Agreement")
is entered into as of the Closing Date (as defined herein) by and
among   Sunrise  Technologies  International,  Inc.,  a  Delaware
corporation,   Pennsylvania  Merchant  Group  Ltd,   a   Delaware
Corporation   (the  "Placement  Agent")  and  the  person   whose
signatures appear on the execution pages of this Agreement.

          This  Agreement is made pursuant to the U.S.  Note  and
Warrant  Purchase  Agreement and the Offshore  Note  and  Warrant
Purchase Agreement between the Company and each of the Purchasers
listed  (the  "Purchase Agreements").  In  order  to  induce  the
Purchasers to enter into the Purchase Agreement and in  order  to
induce the Placement Agent to accept the Placement Agent Warrant,
the  Company  has agreed to provide the registration  rights  set
forth in this Agreement.  The execution of this Agreement by  the
Company  is  a  condition  to  the  closing  under  the  Purchase
Agreement.

          The parties hereby agree as follows:

     1.   Definitions

          Capitalized terms used herein without definition  shall
have   their  respective  meanings  set  forth  in  the  Purchase
Agreement.  As used in this Agreement, the following terms  shall
have the following meanings:

          Closing  Date:   The  date  assigned  thereto  in   the
Purchase Agreement.

          Common  Stock:  The common stock, $.001 par  value  per
share, of the Company.

          Company:  Sunrise Technologies International,  Inc.,  a
Delaware corporation.

          Conversion  Share:  Shares issuable upon the conversion
of the Notes.

          Exchange Act:  The Securities Exchange Act of 1934,  as
amended,  and  the rules and regulations of the  SEC  promulgated
thereunder.

          Losses:  See Section 7 hereof.

          Notes:   The Notes issued to investors pursuant to  the
Purchase Agreements.

          Placement Agent:  Pennsylvania Merchant Group Ltd

          Placement  Agent Warrant:  The Warrant  issued  to  the
Placement  Agent  as  described in  Section  6  of  the  Purchase
Agreements.

                                 1
<PAGE>


          Prospectus:    The   prospectus   included    in    any
Registration   Statement  (including,   without   limitation,   a
prospectus that discloses information previously omitted  from  a
prospectus  filed as part of an effective registration  statement
in  reliance  upon  Securities Act  Rule  430A),  as  amended  or
supplemented  by any prospectus supplement, with respect  to  the
terms   of  the  offering  of  any  portion  of  the  Registrable
Securities covered by such Registration Statement and  all  other
amendments  and  supplements to the prospectus,  including  post-
effective  amendments, and all material incorporated by reference
or deemed to be incorporated by reference in such prospectus.

          Purchase Agreement:  The U.S. Note and Warrant Purchase
Agreement and the Offshore Note and Warrant Purchase Agreement by
and  among the Company and the Purchasers thereunder pursuant  to
which the Note and Warrants were issued.

          Purchasers:   The  purchasers listed on  the  signature
pages to the Purchase Agreements.

          Registrable  Securities:   All  Conversion  Shares  and
Warrant  Shares which are Restricted Securities, and  any  Common
Stock issued or issuable in respect of the Conversion Shares  and
the  Warrant Shares, pursuant to any stock split, stock dividend,
recapitalization, or similar event.  The Notes, Warrants and  the
Placement Agent Warrant are not Registrable Securities hereunder.

          Registration   Expenses:    All   reasonable   expenses
incurred  by  the  Company in complying with  Section  3  hereof,
including  all  registration and filing fees, printing  expenses,
fees  and disbursements of counsel for the Company, and blue  sky
fees  and  expenses in all states in which there is an  exemption
for  issuances of stock traded on the Nasdaq National Market  and
such other states listed in Schedule 1 attached hereto.

          Registration Statement:  Any registration statement  of
the  Company  which  covers  any of  the  Registrable  Securities
pursuant  to  the  provisions of this  Agreement,  including  the
Prospectus,  amendments  and  supplements  to  such  registration
statement, including post-effective amendments, all exhibits, and
all   material  incorporated  by  reference  or  deemed   to   be
incorporated reference in such registration statement.

          Restricted  Securities:   The  Conversion  Shares,  the
Placement  Agent  Warrant and the Warrant  Shares  upon  original
issuance thereof, and at all times subsequent thereto, until,  in
the  case of any such security, it is no longer required to  bear
the  legend set forth on such security pursuant to the  terms  of
the security, the Purchase Agreement and applicable laws.

          Rule  144:  Rule 144 under the Securities Act, as  such
Rule  may  be amended from time to time, or any similar  rule  or
regulation hereafter adopted by the SEC (excluding Rule 144A).

          SEC:  The Securities and Exchange Commission.

          Securities  Act:   The  Securities  Act  of  1933,   as
amended,  and the rules and regulations promulgated  by  the  SEC
thereunder.

                                 2
<PAGE>


          Shelf Registration:  See Section 3(a) hereof.

          Underwritten registration or underwritten offering:   A
registration in which securities of the Company are  sold  to  an
underwriter for reoffering to the public.

          Warrants:   The warrants to purchase shares  of  Common
Stock issued to Purchasers pursuant to the Purchase Agreement.

          Warrant  Shares:  The shares of Common Stock issued  or
issuable  to Purchasers pursuant to the exercise of the  Warrants
and  to  the  Placement Agent upon the exercise of the  Placement
Agent Warrant.

     2.   Securities Subject to this Agreement

          The   securities  entitled  to  the  benefits  of  this
Agreement are the Registrable Securities.

     3.   Shelf Registration

          (a)   Shelf Registration.  The Company shall, not later
than the later of the 60th day after the initial Closing Date  or
the  thirtieth  (30th) day after the Final Closing  Date  of  the
Offering  (the "Filing Date"), prepare and file with  the  SEC  a
Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415 (or any appropriate similar rule  that
may  be adopted by the SEC) under the Securities Act covering the
Registrable  Securities  (the "Shelf  Registration").  The  Shelf
Registration shall be on a form permitting registration  of  such
Registrable Securities for resale by such holders in  the  manner
or  manners  reasonably  designated by them  (including.  without
limitation, one or more underwritten offerings).

          (b)   Effectiveness.  The Company shall use  reasonable
efforts to cause the Shelf Registration to become effective under
the  Securities Act as soon as practicable following  the  Filing
Date.   Subject  to  the  requirements  of  the  Securities   Act
including, without limitation, requirements relating to  updating
prospectuses through post-effective amendments or otherwise,  the
Company   shall  use  reasonable  efforts  to  keep   the   Shelf
Registration continuously effective until the Expiration Date (as
such  term  is defined in the Warrants); provided,  that  in  the
event  of  a  Suspension  Period, as set forth  in  Section  5(d)
hereof,  the Company shall extend the period of effectiveness  of
such  Shelf  Registration by the number  of  days  of  each  such
Suspension  Period, and provided further that the  Company  shall
not  be  required to keep the Shelf Registration  effective  with
respect  to  any  Registrable Securities  that  may  be  sold  in
accordance with Rule 144 under the Securities Act.

          (c)   Priority  on Shelf Registration. If  any  of  the
Registrable  Securities  to  be  registered  pursuant  to   Shelf
Registration  are  to  be sold in a firm commitment  underwritten
offering, and if the managing underwriters advise the Company and
the  holders of such Registrable Securities that in their opinion
the  amount of Registrable Securities proposed to be sold in such
offering  exceeds the amount of Registrable Securities which  can
be  sold  in such offering, there shall be included in such  firm
commitment  underwritten offering the amount of such  Registrable
Securities requested to be included in such registration which in
the  opinion  of 

                                 3
<PAGE>


such underwriters can be sold, and  such  amount
shall be allocated pro rata among the holders of such Registrable
Securities requested to be included in such registration  on  the
basis  of  the  number  shares  of Common  Stock  represented  by
Registrable Securities requested to be included therein  by  such
holders.

     4.   Holdback Agreements.

          (a)    Restrictions  on  Public  Sale  by  Holders   of
Registrable  Securities.  Each holder of  Registrable  Securities
whose  Registrable  Securities  are  covered  by  a  Registration
Statement filed pursuant to Section 3 hereof agrees, if requested
by  the managing underwriters in an underwritten offering (to the
extent  timely notified in writing by the Company or the managing
underwriters),  not to effect any public sale or distribution  of
securities  of  the  Company  of  any  class  included  in   such
Registration  Statement, including a sale pursuant  to  Rule  144
(except as part of such underwritten offering), during the l0-day
period  prior  to,  and  the  90-day  period  beginning  on,  the
effective date of any underwritten offering made pursuant to such
Registration Statement.

          The  foregoing provisions shall not apply to any holder
of   Registrable  Securities  if  such  holder  is  prevented  by
applicable  statute  or regulation from entering  into  any  such
agreement;   provided,  however,  that  any  such  holder   shall
undertake  in its request to participate in any such underwritten
offering  not  to effect any public sale or distribution  of  the
class  of  Registrable  Securities covered by  such  Registration
Statement  (except as part of such underwritten offering)  during
such  period unless it has provided five (5) business days  prior
written  notice  of  such sale or distribution  to  the  managing
underwriter or underwriters.

     5.   Expenses and Procedures.

          (a)    Expenses   of  Registration.   All  Registration
Expenses  (exclusive of underwriting discounts  and  commissions)
shall  be  borne  by  the Company.  Each holder  shall  bear  all
underwriting  discounts, selling commissions,  sales  concessions
and  similar  expenses  applicable  to  the  sale  of  securities
attributable to the Registrable Securities sold by such holder.

          (b)   Registration  Procedures.  In the  case  of  each
registration, qualification or compliance effected by the Company
pursuant to Section 3, the Company will keep the holders  advised
as   to   the  initiation  of  registration,  qualification   and
compliance and as to the completion thereof.  At its expense, the
Company  will  furnish  such  number of  Prospectuses  and  other
documents incident thereto as the holders from time to  time  may
reasonably request.

          (c)   Information.  The Company may require each seller
of  Registrable Securities as to which any registration is  being
effected  to  furnish such information regarding the distribution
of  such  Registrable Securities as the Company may from time  to
time  reasonably  request and the Company may exclude  from  such
registration  the  Registrable  Securities  of  any  seller   who
unreasonably  fails to furnish such information  after  receiving
such request.

          (d)   Delay  or  Suspension.  Notwithstanding  anything
herein  to the contrary, the Company may, at any time, delay  the
filing  of the Shelf Registration for a period of up to  60  days

                                 4
<PAGE>


following  the  Filing Date or suspend the effectiveness  of  any
Registration  Statement for a period of up  to  90  days  in  the
aggregate  in  any calendar year, as appropriate  (a  "Suspension
Period"),   by  giving  notice  to  each  holder  of  Registrable
Securities to be included in the Registration Statement,  if  the
Company shall have determined that the Company may be required to
disclose any material corporate development which disclosure  may
have   a  material  effect  on  the  Company.   Each  holder   of
Registrable  Securities agrees by acquisition of such Registrable
Securities that, upon receipt of any notice from the Company of a
Suspension   Period,  such  holder  shall  forthwith  discontinue
disposition  of  such  Registrable  Securities  covered  by  such
Registration  Statement or Prospectus until such  holder  (i)  is
advised  in writing by the Company that the use of the applicable
Prospectus  may  be  resumed,  (ii)  has  received  copies  of  a
supplemental or amended prospectus, if applicable, and (iii)  has
received  copies of any additional or supplemental filings  which
are  incorporated or deemed to be incorporated  by  reference  in
such Prospectus.  The Company shall prepare, file and furnish  to
each  holder  of  Registrable  Securities  immediately  upon  the
expiration  of any Suspension Period, appropriate supplements  or
amendments,  if  applicable,  to the Prospectus  and  appropriate
documents,  if  applicable,  incorporated  by  reference  in  the
Registration Statement.

     6.   Indemnification.

          (a)   Indemnification by Company.  The  Company  shall,
without  limitation as to time, indemnify and hold  harmless,  to
the  full  extent  permitted by law, each holder  of  Registrable
Securities,  its officers, directors, agents and employees,  each
person who controls such holder (within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act), and the
officers,  directors, agents or employees of any such controlling
person,   from   and   against  all  losses,   claims,   damages,
liabilities, costs (including, without limitation, all reasonable
attorneys'  fees)  and  expenses  (collectively,  "Losses"),   as
incurred,  arising out of or based upon any untrue  statement  or
alleged  untrue  statement of a material fact  contained  in  any
Registration Statement, Prospectus or preliminary prospectus,  or
arising out of or based upon any omission or alleged omission  of
a  material  fact required to be stated therein or  necessary  to
make  the statements therein in light of the circumstances  under
which  they  were  made  (in  the case  of  any  Prospectus)  not
misleading,  except  insofar as the same are  based  solely  upon
information  furnished  to the Company by  such  holder  for  use
therein; provided, however, that the Company shall not be  liable
in  any such case to the extent that any such Loss arises out  of
or  is based upon an untrue statement or alleged untrue statement
or   omission   or  alleged  omission  made  in  any  preliminary
prospectus  or Prospectus if (i) such holder failed  to  send  or
deliver a copy of the Prospectus or Prospectus supplement with or
prior  to  the delivery of written confirmation of  the  sale  of
Registrable  Securities  and (ii) the  Prospectus  or  Prospectus
supplement   would  have  corrected  such  untrue  statement   or
omission.    If  requested,  the  Company  shall  also  indemnify
underwriters,  selling  brokers,  dealers  managers  and  similar
securities   industry   professionals   participating   in    the
distribution, their officers, directors, agents and employees and
each  person  who controls such persons (within  the  meaning  of
Section  15  of the Securities Act or Section 20 of the  Exchange
Act)  to  the same extent as provided above with respect  to  the
indemnification of the holders of Registrable Securities.

          (b)    Indemnification   by   Holder   of   Registrable
Securities.   In  connection with any Registration  Statement  in
which  a holder of Registrable Securities is participating,  such
holder of Registrable Securities shall furnish to the Company  in
writing  such  information as the Company 

                                 5
<PAGE>


may reasonably  request
for  use  in  connection  with  any  Registration  Statement   or
Prospectus.   Such  holder hereby agrees to  indemnify  and  hold
harmless,  to the full extent permitted by law, the Company,  and
its  officers, directors, agents and employees, each  person  who
controls  the Company (within the meaning of Section  15  of  the
Securities  Act  or  Section  20 of the  Exchange  Act)  and  the
officers,  directors, agents or employees of any such controlling
person, from and against all Losses arising out of or based  upon
any  untrue  statement  of  a  material  fact  contained  in  any
Registration Statement, Prospectus or preliminary prospectus,  or
arising  out  of  or based upon any omission of a  material  fact
required  to be stated therein or necessary to make the statement
therein in light of the circumstances under which they were  made
(in  the  case of any Prospectus) not misleading, to the  extent,
but only to the extent, that such untrue statement or omission is
contained  in  any information so furnished in  writing  by  such
holder  to  the  Company for use in such Registration  Statement,
Prospectus  or  preliminary  prospectus.   Such  indemnity  shall
remain  in  full force and effect regardless of any investigation
made  by  or  on behalf of the Company or any holder and  any  of
their  respective  directors,  officers,  agents,  employees   or
controlling  persons (within the meaning of  Section  15  of  the
Securities  Act  or  Section 20 of the Exchange  Act)  and  shall
survive  the  transfer of such securities by  such  holder.   The
Company   shall   be   entitled  to  receive   indemnities   from
accountants,  underwriters, selling brokers, dealer managers  and
similar  securities industry professionals participating  in  the
distribution to the same extent as provided above with respect to
information  so  furnished  by  such  persons  specifically   for
inclusion   in   any   Registration  Statement,   Prospectus   or
preliminary prospectus, provided, that the failure of the Company
to obtain any such indemnity shall not relieve the Company of any
of its obligations hereunder.

          (c)   Conduct of Indemnification Proceedings.   If  any
action or proceeding (including any governmental investigation or
inquiry) shall be brought or any claim shall be asserted  against
any  person  entitled  to  indemnity hereunder  (an  "indemnified
party"),  such indemnified party shall promptly notify the  party
from which such indemnity is sought (the "indemnifying party") in
writing,  and  the  indemnifying party shall assume  the  defense
thereof,   including   the  employment  of   counsel   reasonably
satisfactory to the indemnified party and the payment of all fees
and  expenses  incurred in connection with the  defense  thereof.
All  such  fees  and  expenses (including any fees  and  expenses
incurred in connection with investigating or preparing to  defend
such  action  or  proceeding) shall be paid  to  the  indemnified
party,  as incurred, within 20 days of written notice thereof  to
the indemnifying party; provided, however, that if, in accordance
with this Section 8, the indemnifying party is not liable to  the
indemnified  party,  such  fees and expenses  shall  be  returned
promptly  to the indemnifying party.  Any such indemnified  party
shall  have  the  right to employ separate counsel  in  any  such
action,  claim  or proceeding and to participate in  the  defense
thereof, but the fees and expenses of such counsel shall  be  the
expense  of  such  indemnified party unless (a) the  indemnifying
party  has  agreed  to  pay  such  fees  and  expenses,  (b)  the
indemnifying  party  shall have failed  promptly  to  assume  the
defense of such action, claim or proceeding and to employ counsel
reasonably  satisfactory to the indemnified  party  in  any  such
action, claim or proceeding, or (c) the named parties to any such
action,  claim  or  proceeding (including any impleaded  parties)
include  both such indemnified party and the indemnifying  party,
and  such  indemnified party shall have been advised  by  counsel
that  there  may  be one or more legal defenses available  to  it
which are different from or additional to those available to  the
indemnifying  party  (in  which case, if such  indemnified  party
notifies  the  

                                 6
<PAGE>


indemnifying party in writing that  it  elects  to
employ separate counsel at the expense of the indemnifying party,
the  indemnifying party shall not have the right  to  assume  the
defense  of  such action, claim or proceeding on behalf  of  such
indemnified  party,  it  being  understood,  however,  that   the
indemnifying  party shall not, in connection with  any  one  such
action, claim or proceeding or separate but substantially similar
or   related   actions,  claims  or  proceedings  in   the   same
jurisdiction  arising  out  of the same  general  allegations  or
circumstances, be liable for the reasonable fees and expenses  of
more   than  one  separate  firm  of  attorneys   (together  with
appropriate  local counsel) at any time for all such  indemnified
parties,  unless  in the opinion of counsel for such  indemnified
party  a  conflict of interest may exist between such indemnified
party  and any other of such indemnified parties with respect  to
such action, claim or proceeding, in which event the indemnifying
party  shall  be obligated to pay the fees and expenses  of  such
additional  counsel  or  counsels). No  indemnifying  party  will
consent  to  entry of any judgment or enter into  any  settlement
which  does  not  include as an unconditional  term  thereof  the
release  of such indemnified party from all liability in  respect
to  such  claim or litigation without the written consent  (which
consent  will  not be unreasonably withheld) of  the  indemnified
party.  No  indemnified  party shall  consent  to  entry  of  any
judgment or enter into any settlement without the written consent
(which  consent  will  not  be  unreasonably  withheld)  of   the
indemnifying  party  from  which  indemnity  or  contribution  is
sought.

          (d)  Contribution. If the indemnification provided  for
in  this  Section 6 is unavailable to an indemnified party  under
Section  6(a) or 6(b) hereof (other than by reason of  exceptions
provided  in those Sections) in respect of any Losses, then  each
applicable  indemnifying  party  in  lieu  of  indemnifying  such
indemnified party shall contribute to the amount paid or  payable
by  such  indemnified party as a result of such Losses,  in  such
proportion as is appropriate to reflect the relative fault of the
indemnifying party and indemnified party in connection  with  the
actions, statements or omissions which resulted in such Losses as
well as any other relevant equitable considerations. The relative
fault  of such indemnifying party and the indemnified party shall
be  determined by reference to, among other things,  whether  any
action  in  question, including any untrue statement  or  alleged
untrue  statement  of  a  material fact or  omission  or  alleged
omission  of  a  material fact, has been taken  or  made  by,  or
relates  to information supplied by, such indemnifying  party  or
indemnified  party, and the parties' relative intent,  knowledge,
access to information and opportunity to correct or prevent  such
action,  statement or omission. The amount paid or payable  by  a
party  as  a  result  of any Losses shall be deemed  to  include,
subject  to the limitations set forth in Section 6(c), any  legal
or  other  fees or expenses reasonably incurred by such party  in
connection  with  any  action,  suit,  claim,  investigation   or
proceeding.

          The  parties hereto agree that it would not be just and
equitable  if  contribution pursuant to this  Section  6(d)  were
determined  by  pro  rata allocation or by any  other  method  of
allocation  which  does  not  take  into  account  the  equitable
considerations   referred   to  in  the   immediately   preceding
paragraph.  No  person  guilty  of  fraudulent  misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation.

                                 7
<PAGE>


     7.   Rule 144

          The Company shall file the reports required to be filed
by it under the Securities Act and the Exchange Act and the rules
and regulations adopted by the SEC thereunder, and will take such
further  action  as  any  holder of  Registrable  Securities  may
reasonably request, all to the extent required from time to  time
to  enable  such  holder to sell Registrable  Securities  without
registration  under the Securities Act within the  limitation  of
the exemption provided by Rule 144 or Rule 144A. Upon the request
of  any  holder  of  Registrable Securities,  the  Company  shall
deliver  to  such holder a written statement as  to  whether  the
Company  has  complied  with such information  and  requirements.
Notwithstanding the foregoing, nothing in this Section 7 shall be
deemed  to  require the Company to register any of its securities
under any section of the Exchange Act.

     8.   Underwritten Registrations.

          If  any  of the Registrable Securities covered  by  any
Shelf  Registration  are to be sold in an underwritten  offering,
the  investment  banker  or investment  bankers  and  manager  or
managers  that will administer the offering will be  selected  by
the  Company, provided that such investment bank or manager shall
be  reasonably  satisfactory  to a majority  of  the  holders  of
Registrable   Securities  to  be  included  in  the  underwritten
offering.

          No   person   may   participate  in  any   underwritten
registration hereunder unless such person (i) agrees to sell such
person's  Registrable  Securities on the basis  provided  in  any
underwriting  arrangements  approved  by  the  persons   entitled
hereunder  to  approve such arrangements, and (ii) completes  and
executes  all  questionnaires, powers of  attorney,  indemnities,
underwriting  agreements and other documents required  under  the
terms of such underwriting arrangements.

     9.   Miscellaneous

          (a)   Amendments and Waivers.  The provisions  of  this
Agreement, including the provisions of this sentence, may not  be
amended,  modified or supplemented, and waivers  or  consents  to
departures from the provisions hereof may not be given unless the
Company  obtains the written consent of the Placement  Agent  and
the  holders  of  at  least  66  2/3%  of  the  then  outstanding
Registrable  Securities affected by such amendment,  modification
or  supplement.   Notwithstanding  the  foregoing,  a  waiver  or
consent  to depart from the provisions hereof with respect  to  a
matter  which  relates exclusively to the rights  of  holders  of
Registrable  Securities whose securities are being sold  pursuant
to  a  Registration  Statement and which  does  not  directly  or
indirectly affect the rights of holders of Registrable Securities
whose securities are not being sold pursuant to such Registration
Statement  may  be  given  by  holders  of  a  majority  of   the
Registrable Securities being sold by such holders.

          (b)   Notices.   All  notices and other  communications
provided  for or permitted hereunder shall be made in writing  by
hand-delivery, registered first-class mail, next day air courier,
telex,   or   telecopy:   (i)  If  to  a  holder  of  Registrable
Securities, at the most current address given by such  holder  to
the   Company   in  accordance  with  the  provisions   of   this
Section  9(b), 

                                 8
<PAGE>


which address initially is, with respect  to  each
purchaser,  the address set forth on the signature page  attached
hereto;  and (ii) if to the Company initially at the address  set
forth  on  the  first page of the Purchase Agreement,  attention:
Secretary and thereafter at such other address, notice  of  which
is  given in accordance with the provisions of this Section 9(b),
with  a copy to Thelen, Marrin, Johnson & Bridges LLP, San  Jose,
CA.

          All such notices and communications shall be deemed  to
have  been  duly  given:  when delivered by hand,  if  personally
delivered; two business days after being deposited in  the  mail,
postage prepaid, if mailed; one business day after being sent  by
next  day  air courier; when answered back, if telexed; and  when
receipt acknowledged, if telecopied.

          (c)   Transfer  of  Registration  Rights.   The  rights
granted  to the holders pursuant to this Agreement to  cause  the
Company to register securities may be assigned in connection with
the  transfer, assignment or sale of any Registrable Security  to
the  extent  such  securities  and  rights  may  be  transferred,
assigned  or  sold  pursuant  to  applicable  laws  and  to   the
agreements  to which the particular holder is a party;  provided,
however,  that no transfer or assignment of such rights shall  be
effective  or valid unless the purchaser, transferee or assignee,
after  giving effect to the transfer, assignment or sale  of  the
Registrable Securities, owns or has the right to acquire at least
5,000 shares of Common Stock.

          (d)   Counterparts.  This Agreement may be executed  in
any  number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be  deemed  to
be  an  original and all of which taken together shall constitute
one and the same agreement.

          (e)   Headings.  The headings in this Agreement are for
convenience  of reference only and shall not limit  or  otherwise
affect the meaning hereof.

          (f)   Governing Law.  This Agreement shall be  governed
by  and construed in accordance with the laws of the Commonwealth
of Pennsylvania without regard to principles of conflict of laws.

          (g)  Severability.  If any term, provision, covenant or
restriction  of  this Agreement is held by a court  of  competent
jurisdiction to be invalid, void or unenforceable, the  remainder
of  the  terms, provisions, covenants and restrictions set  forth
herein shall remain in full force and effect and shall in no  way
be  affected,  impaired or invalidated, and  the  parties  hereto
shall  use  their best efforts to find and employ an  alternative
means  to  achieve the same or substantially the same  result  as
that   contemplated   by  such  term,  provision,   covenant   or
restriction.  It  is  hereby stipulated and declared  to  be  the
intention  of  the  parties that they  would  have  executed  the
remaining  terms, provisions, covenants and restrictions  without
including  any  of such which may be hereafter declared  invalid,
void or unenforceable.

          (h)   Entire Agreement.  This Agreement is intended  by
the  parties  to be a final expression of their agreement  and  a
complete   and   exclusive  statement  of   the   agreement   and
understanding  of the parties hereto in respect  of  the  subject
matter  contained  herein. There are no  restrictions,  promises,
warranties  nor  undertakings, other  than  those  set  forth  or
referred  to  herein  

                                 9
<PAGE>


with  respect to  the  registration  rights
granted  by  the  Company  with respect to  the  securities  sold
pursuant to the Purchase Agreement. This Agreement supersedes all
prior  agreements  and understandings between  the  parties  with
respect to such subject matter.

          (i)  Attorneys' Fees.  In any action proceeding brought
to  enforce  any  provision  of  this  Agreement,  or  where  any
provision hereof is validly asserted as a defense, the successful
party shall be entitled to recover reasonable attorneys' fees  in
addition  to  its  costs  and expenses and  any  other  available
remedy.

          (j)   Expiration.  This Agreement shall expire  on  the
earlier of (i) the date on which all Registrable Securities  have
been sold by the Purchasers and (ii) the fifth anniversary of the
Closing Date.

          IN  WITNESS  WHEREOF, the parties  have  executed  this
agreement as of the date first written above.

                       SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
                       
                       
                       
                       By:______________________________________
                          David Light
                          President and Chief Executive Officer
                          
                       
                       
                       PENNSYLVANIA MERCHANT GROUP LTD
                       
                       
                       
                       By:______________________________________
                          
                          
                                 10                        
                       



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission